Longitudinal profiling of anti-factor VIII antibodies in Japanese patients with congenital hemophilia A during factor VIII replacement and immune-tolerance induction therapy-Reference-Cited by-同舟云学术

Longitudinal profiling of anti-factor VIII antibodies in Japanese patients with congenital hemophilia A during factor VIII replacement and immune-tolerance induction therapy

Published:2022-05-03 Issue:3 Volume:116 Page:423-433
ISSN:0925-5710
Container-title:International Journal of Hematology
language:en
Short-container-title:Int J Hematol

Author:

Yoshimura Takuji^ORCID,Furukawa Shoko,Oda Akihisa,Matsumoto Tomoko,Sasai Kana,Shima Midori,Nogami Keiji

Funder

Japan Society for the Promotion of Science

Sanofi

Publisher

Springer Science and Business Media LLC

Subject

Hematology

Link

https://link.springer.com/content/pdf/10.1007/s12185-022-03359-z.pdf

Reference39 articles.

1. Nilsson IM, Hedner U, Ahlberg A. Haemophilia prophylaxis in Sweden. Acta Paediatr Scand. 1976;65(2):129–35.

2. Manco-Johnson MJ, Abshire TC, Shapiro AD, Riske B, Hacker MR, Kilcoyne R, et al. Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. N Engl J Med. 2007;357(6):535–44.

3. Walsh CE, Soucie JM, Miller CH. United States Hemophilia Treatment Center N. Impact of inhibitors on hemophilia A mortality in the United States. Am J Hematol. 2015;90(5):400–5.

4. Fischer K, Lewandowski D, van den Berg HM, Janssen MP. Validity of assessing inhibitor development in haemophilia PUPs using registry data: the EUHASS project. Haemophilia. 2012;18(3):241–6.

5. Witmer C, Young G. Factor VIII inhibitors in hemophilia A: rationale and latest evidence. Ther Adv Hematol. 2013;4(1):59–72.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High levels of anti–factor VIII immunoglobulin G4 and immunoglobulin G total are associated with immune tolerance induction failure in people with congenital hemophilia A and high-responding inhibitors;Research and Practice in Thrombosis and Haemostasis;2024-05

2. A review of the rationale for gene therapy for hemophilia A with inhibitors: one-shot tolerance and treatment?;Journal of Thrombosis and Haemostasis;2023-11